3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
4
Primary Myelofibrosis
3
Polycythemia Vera
2
Myelodysplastic Syndromes
2
Lymphoma, T-Cell
2
Leukemia
2
Graft vs Host Disease
2
Thrombocythemia, Essential
1
Thalassemia
1
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Glioma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
Cyclophosphamide
23
fludarabine
15
fludarabine phosphate
10
Methotrexate
10
blinatumomab
9
Whole-Body Irradiation
9
Vincristine
7
Specimen Handling
7
Dexamethasone
7
merphos
6
Tacrolimus
6
Mycophenolic Acid
6
Stem Cell Transplantation
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Mercaptopurine
5
Melphalan
5
Leukapheresis
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Cytarabine
5
Cyclosporine
5
Biopsy
5
pegaspargase
4
Prednisone
4
Magnetic Resonance Spectroscopy
4
Etoposide
4
Calcium Dobesilate
4
Busulfan
4
prednylidene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
ruxolitinib
×
30 days
×
Clear all
No trials found.